Illumina News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

18.11.14	BioMérieux, Illumina To Develop NGS Solution For Service Labs (RTTNews)
18.11.14	bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections (Businesswire)
21.10.14	Illumina Profit Surges, Lifts Outlook; Shares Up 10% (RTTNews)
20.10.14	Illumina Q3 Results Trounce Estimates; Boosts FY14 Outlook (RTTNews)
20.10.14	Earnings Watch For October 20 (AAPL, IBM, TXN, HAL, RMBS) (RTTNews)
21.08.14	Illumina Teams Up With AstraZeneca, Janssen And Sanofi - Quick Facts (RTTNews)
01.08.14	UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases (Businesswire)
30.06.14	Biomnis, Genoma und das Zentrum für Humangenetik und Laboratoriumsdiagnostik in Martinsried schliessen Verträge mit Illumina zwecks Verbreitung von nicht invasiven Pränataltests in ganz Europa (Businesswire)
30.06.14	Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, Enter Agreements with Illumina to Expand Access for Non-Invasive Prenatal Testing Across Europe (Businesswire)
25.04.14	Illumina Files New Patent Suit Against Ariosa Diagnostics (RTTNews)
23.04.14	QRxPharma Snubbed Again, Illumina Shines, ENTA Gets Rich, LLY Opens Wallet (RTTNews)
23.04.14	Illumina Q1 Profit Rises, Lifts FY Outlook; Shares Jump 10% (RTTNews)
23.04.14	After-market Movers For April 22 (T, AMGN, YUM, GILD, SWKS, SMCI, ILMN, SKX, CREE, ISRG) (RTTNews)
22.04.14	Illumina Posts Q1 Profit - Quick Facts (RTTNews)
24.02.14	Science for Life Laboratory Joins the Illumina Genome Network (Businesswire)
29.01.14	Illumina Profit Tops Estimates, But Guides FY14 Below Consensus (RTTNews)
28.01.14	Illumina Profit Tops Street, Details Weak FY14 Adj. EPS Outlook; Stock Down 3% (RTTNews)
23.12.13	INDEX-MONITOR: Fünf Wechsel im Nasdaq 100 (dpa-afx)
14.12.13	INDEX-MONITOR/Kurz vor Weihnachten: Fünf Wechsel im Nasdaq 100 (dpa-afx)
29.10.13	INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch (RTTNews)
28.10.13	Illumina To Buy NextBio; Backs 2013 Goals - Quick Facts (RTTNews)
22.10.13	After-market Movers For Oct 21 (NFLX, VMW, TXN, DFS, SYMM, ILMN, DEPO, OXBT,RIG) (RTTNews)
21.10.13	Illumina Q3 Profit Rises, Lifts FY Outlook; Shares Rise (RTTNews)
21.10.13	Illumina Q3 Profit Rises, Lifts FY13 Outlook - Quick Facts (RTTNews)
21.10.13	ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc. (PR Newswire)
21.10.13	University of Cambridge, Genomics England Ltd., and Illumina Collaborate to Sequence 10,000 Whole Human Genomes for National Health Service Patients (Businesswire)
21.10.13	Earnings Watch For October 21 (HAL, MCD, NFLX, TXN, VMW) (RTTNews)
16.10.13	Successful Launches, Upcoming Conference Calls, Signing of Agreements, and Trial Results - Research Report on Vertex, Illumina, Alexion, VIVUS, and Endocyte (PR Newswire)
07.10.13	Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon (PR Newswire)
26.09.13	FDA Approvals, New Appointments, Positive Litigation Outcomes and Partnerships - Research Report on Edwards Lifesciences, Illumina, Teva, Alere, and Dr. Reddy's (PR Newswire)
25.09.13	Global Genomics Group (G3) and Illumina to Partner on Cardiovascular Genomics (PR Newswire)
25.09.13	Illumina Applies CE Mark to Expanded MiSeqDx™ System (Businesswire)
12.09.13	FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina (PR Newswire)
27.08.13	New Programs, Product Launches, Corporate Announcements and Financial Results - Research Report on Aetna, Illumina, Pharmacyclics, WellCare, and BioCryst (PR Newswire)
12.08.13	Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer (PR Newswire)
02.08.13	Expanding R&D Programs, Clinical Trials, Drug Applications and Acquisitions, Advancing to Help Patients with Unmet Medical Needs - Research Report on Questcor, BioMarin, Vanda, Illumina and Theravance (PR Newswire)
24.07.13	Marketing Applications, Product Launches, Commencement of Studies, Collaborations, and Release of Funding - Research Report on Biogen Idec, Illumina, Santarus, Celsion, and BioCryst (PR Newswire)
24.07.13	Illumina Shares Up 6% As Q2 Results Top View, Boosts 2013 Outlook (RTTNews)
24.07.13	After-market Movers For July 23 (AAPL, EA, VMW, TTHI, ILMN, PNRA, BRCM) (RTTNews)
23.07.13	Illumina Q2 Results Top Estimates; Acquires Advanced Liquid Logic - Quick Facts (RTTNews)
18.07.13	Complete Genomics, Illumina Settle Patent Dispute (RTTNews)
01.07.13	Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System (Businesswire)
07.01.13	Wall Street-Schluss: Abschläge, Bank of America im Fokus (Aktiencheck)
07.01.13	Börsen in Europa-Schluss: Schwacher Wochenauftakt, Banken im Blick (Aktiencheck)
07.01.13	Wall Street Update: Deutliche Abschläge im Mittagshandel (Aktiencheck)
16.10.12	ROUNDUP 2: Krebsmittel zahlen sich für Roche aus - Kein Kommentar zu Illumina (dpa-afx)
20.09.12	Qiagen steigt ins Geschäft der Gen-Entschlüsselung ein (dpa-afx)
19.09.12	Illumina Acquires BlueGnome, Leading Provider of Cytogenetics and In Vitro Fertilization Screening Solutions (Businesswire)
20.06.12	Illumina Announces RapidTrack Whole Genome Sequencing Service (Businesswire)
18.06.12	Illumina Files Second Patent Infringement Suit Against Complete Genomics, Inc. (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.32	1.80 %	K V
UBS Group	28.05	1.37 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
Swiss Re	129.70	0.78 %	K V
ABB	49.38	0.73 %	K V
Nestle	76.38	0.03 %	K V
Alcon	78.00	0.00 %	K V
Givaudan	3’865.00	-0.39 %	K V
CieFinRichemont	121.25	-0.53 %	K V
Sonova Hldg	301.30	-0.89 %	K V

mehr

20.11.24		Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone
20.11.24		Schwacher Handel: NASDAQ 100 schwächelt mittags
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
18.11.24		Pluszeichen in New York: NASDAQ 100 zum Ende des Montagshandels in Grün
18.11.24		Börse New York in Grün: Börsianer lassen NASDAQ 100 nachmittags steigen
18.11.24		NASDAQ-Handel: NASDAQ 100 zeigt sich am Montagmittag fester

20.11.24

Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone

20.11.24

Schwacher Handel: NASDAQ 100 schwächelt mittags

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

18.11.24

Pluszeichen in New York: NASDAQ 100 zum Ende des Montagshandels in Grün